Terms: = Prostate cancer AND BIRC3, AIP1, 330, ENSG00000023445, HIAP1, Q13489, MIHC, CIAP2, API2, cIAP2, MALT2, hiap-1, RNF49, HAIP1 AND Staging
11 results:
1. Cost-Effectiveness Modeling of prostate-Specific Membrane Antigen Positron Emission Tomography with Piflufolastat F 18 for the Initial Diagnosis of Patients with prostate cancer in the United States.
Yee CW; Harvey MJ; Xin Y; Kirson NY
Pharmacoeconomics; 2024 Feb; 42(2):231-247. PubMed ID: 37934376
[TBL] [Abstract] [Full Text] [Related]
2. Multi-Institutional Clinical Outcomes of Biopsy Gleason Grade Group 5 prostate cancers Treated With Contemporary High-Dose Radiation and Long-Term Androgen Deprivation Therapy.
Chilukuri S; Mallick I; Agrawal A; Maitre P; Arunsingh M; James FV; Kataria T; Narang K; Gurram BC; Anand AK; Utreja N; Dutta D; Pavamani S; Mitra S; Mallik S; Mahale N; Chandra M; Chinnachamy AN; Shahid T; Raghunathan MS; Kannan V; Mohanty SK; Basu T; Hotwani C; Panigrahi G; Murthy V
Clin Oncol (R Coll Radiol); 2023 Jul; 35(7):454-462. PubMed ID: 37061457
[TBL] [Abstract] [Full Text] [Related]
3. Consecutive transperineal prostatic template biopsies employing cognitive and systematic approach: a single center study.
Bhat Z; Bhat A; Mahmalji W
Aging Male; 2020 Dec; 23(5):953-957. PubMed ID: 31318579
[TBL] [Abstract] [Full Text] [Related]
4. Diagnostic accuracy of
Kim SJ; Lee SW
Br J Radiol; 2019 Sep; 92(1101):20190193. PubMed ID: 31265330
[TBL] [Abstract] [Full Text] [Related]
5. Evaluation of prostate cancer Stage Groups Updated in the 8th Edition of the American Joint Committee on cancer Tumor-Node-Metastasis staging Manual.
Lee H; Lee M; Byun SS; Lee SE; Hong SK
Clin Genitourin Cancer; 2019 Feb; 17(1):e221-e226. PubMed ID: 30472041
[TBL] [Abstract] [Full Text] [Related]
6. Our experience in the management of prostate cancer in renal transplant recipients.
Narváez A; Suarez J; Riera L; Castells-Esteve M; Cocera R; Vigués F
Actas Urol Esp (Engl Ed); 2018 May; 42(4):249-255. PubMed ID: 29395386
[TBL] [Abstract] [Full Text] [Related]
7. Laparoscopic radical prostatectomy for high-risk prostate cancer.
Di Benedetto A; Soares R; Dovey Z; Bott S; McGregor RG; Eden CG
BJU Int; 2015 May; 115(5):780-6. PubMed ID: 24802619
[TBL] [Abstract] [Full Text] [Related]
8. Overuse of imaging for staging low risk prostate cancer.
Choi WW; Williams SB; Gu X; Lipsitz SR; Nguyen PL; Hu JC
J Urol; 2011 May; 185(5):1645-9. PubMed ID: 21419444
[TBL] [Abstract] [Full Text] [Related]
9. Comparing the costs of radiation therapy and radical prostatectomy for the initial treatment of early-stage prostate cancer.
Burkhardt JH; Litwin MS; Rose CM; Correa RJ; Sunshine JH; Hogan C; Hayman JA
J Clin Oncol; 2002 Jun; 20(12):2869-75. PubMed ID: 12065564
[TBL] [Abstract] [Full Text] [Related]
10. Use of artificial neural networks in the clinical staging of prostate cancer: implications for prostate brachytherapy.
Gamito EJ; Stone NN; Batuello JT; Crawford ED
Tech Urol; 2000 Jun; 6(2):60-3. PubMed ID: 10798801
[TBL] [Abstract] [Full Text] [Related]
11. Laparoscopic pelvic lymph node dissection, laparoscopically assisted seminal vesicle mobilization, and total perineal prostatectomy versus radical retropubic prostatectomy for prostate cancer.
Teichman JM; Reddy PK; Hulbert JC
Urology; 1995 May; 45(5):823-30. PubMed ID: 7538244
[TBL] [Abstract] [Full Text] [Related]
